K-numberK250299
Device nameCT/ MR Tandem and Ovoid Set
ApplicantVarian Medical Systems, Inc.
Product codeJAQ
Device classClass II
Decision dateMay 9, 2025
DecisionSubstantially Equivalent
Regulation892.5700
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The CT/MR Tandem and Ovoid Set is a gynecological brachytherapy applicator designed for cancer treatment of the uterus, cervix, paracervix, endometrium, and vagina using high-dose-rate (HDR) brachytherapy. The applicator guides a remote-controlled radioactive source to target locations during radiation therapy and is compatible with both CT and MR imaging.

Technological characteristics

The subject device differs from the predicate (K241853) in material composition—using PEEK and PAEK instead of stainless steel, PPSU, PEEK, and titanium—and achieves MR safe (rather than MR conditional) status due to its fully non-metallic, non-conductive design. It supports only HDR brachytherapy, not PDR, and is limited to 100 sterilization cycles versus the predicate's 250–500 cycles. Several new components were added to the design, including an assembly module, guide tube collector, clamping unit, and disassembly pin, all marked 'CT/MR'.

Test standards cited

Testing included biocompatibility per ISO 10993 (parts 1, 2, 5, 6, 10, 11, 12, 17, 18, 23), MR safety per ASTM F2503-23, design verification/validation per 21 CFR §820, ISO 13485, and ISO 14971, human factors per IEC 62366, sterilization per EN ISO 17665-1, and cleaning/processing per EN ISO 17664-1 and EN 60601-2-17:2015.

Substantial equivalence argument

The intended use and indications for use are substantially equivalent to the predicate. Although the subject device narrows the scope to HDR only (excluding PDR) and uses non-metallic materials, these differences do not raise new safety or effectiveness questions; the all-polymer construction actually improves MR safety. Verification, validation, and conformance to relevant consensus standards demonstrate equivalent safety and performance. The design differences—new components and fewer sterilization cycles—reflect material properties rather than altered function; the applicator still guides radioactive source placement identically to the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →